Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Divi Labs snaps six-session winning streak as investors book profits

** India's Divi's Laboratories DIVI.NS drops 2% to 6,750 rupees, which analysts attribute to profit booking

** Stock set to snap six-session gaining streak in which it climbed ~7%

** One of India's top API makers posts 35% Y/Y Q2 profit jump on strength in mainstay API business; rev from ops up 16% Y/Y

** "Divi's Q2 results show strong performance, however, the stock correction we see is after the gains that it has seen over the past few sessions, so some profit booking is expected," says Shrikant Akolkar, an analyst with Nuvama

** Avg rating on DIVI at "hold"; median PT is 6,499 rupees - data compiled by LSEG

** YTD, DIVI up ~11% vs 5.2% decline in pharma index .NIPHARM

 (Reporting by Kashish Tandon in Bengaluru)

 ((Kashish.tandon@thomsonreuters.com))

Recent news on Divi's Laboratories

See all news